After 2008, annual research productivity increased to more than 1000 papers when new hypotheses regarding the origin of high-grade serous subtypes [10] and the association of ovarian cancers with ARID1A mutations and endometriosis were proposed [8, 9]. Here, ARID1A is linked to ovarian cancer.